Duke University: Lung Neoplasms trials

The registry lists 21 Lung Neoplasms studies with Duke University as lead sponsor. 1 are open to participants now and 11 have results posted.

Early Phase 1 1Phase 1 3Phase 2 10No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lung Cancer and Aging: Improving Well-being for Older Adults With Lung CancerNot yet recruitingNCT06636721Not applicable
• DBT for Metastatic Lung CancerCompletedNCT04973436Not applicableResults posted
• Resilience Measurement in Older Adults With Late-Stage Lung CancerCompletedNCT04825912Not applicableResults posted
• Atezolizumab and Bevacizumab in EGFR Mutant NSCLC in Patients With Progressive Disease After Receiving OsimertinibTerminatedNCT04099836Phase 2Results posted
• Self-System Therapy for Older Adults With Lung CancerCompletedNCT04057196Not applicableResults posted
• A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsCompletedNCT03434418Phase 2Results posted
• Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung CancerTerminatedNCT02157116Phase 2Results posted
• Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571TerminatedNCT02127372Phase 1/2Results posted
• Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01820754Phase 2Results posted
• Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLCTerminatedNCT00787267Phase 2Results posted
• Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung CancerTerminatedNCT00564876Phase 2Results posted
• Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00509366Phase 2Results posted
• Virtual Agent Feasibility in Oncology Patients (NTT Data)WithdrawnNCT06682013Not applicable
• SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung CancerWithdrawnNCT04650490Phase 2
• Olympus - 19-gauge NeedleCompletedNCT03270670
• Magnetic Resonance Imaging (MRI) in MotionCompletedNCT02019199
• Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic MalignanciesCompletedNCT00921739Phase 1
• Early Detection of Lung Cancer Via Bi-plane Correlation Chest ImagingCompletedNCT00673283Early Phase 1
• Feasibility of Exercise With Post-Op Lung Cancer PatientsCompletedNCT00636571Not applicable
• EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00041028Phase 2
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00004604Phase 1